STERIS plc Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
STERIS plc (STE) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $201.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-07
- STERIS plc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $201.00M, a 12.92% increase year-over-year.
- STERIS plc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $220.30M, a 49.97% increase year-over-year.
- STERIS plc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $194.30M, a 12.05% increase year-over-year.
- STERIS plc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $192.50M, a 27.15% increase year-over-year.
- STERIS plc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2026 was $785.10M, a 28.37% increase from fiscal 2025.
- STERIS plc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $611.60M, a 10.54% increase from fiscal 2024.
- STERIS plc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $553.30M, a 0.52% decline from fiscal 2023.
- STERIS plc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $556.20M, a 95.53% increase from fiscal 2022.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $201.00M 10-Q · filed 2026-08-07 | $421.30M derived: sum of 2 quarters · filed 2026-08-07 | $615.60M derived: sum of 3 quarters · filed 2026-08-07 | $808.10M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $220.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $414.60M derived: sum of 2 quarters · filed 2026-05-29 | $607.10M derived: sum of 3 quarters · filed 2026-05-29 | $785.10M 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $194.30M 10-Q · filed 2026-02-06 | $386.80M derived: sum of 2 quarters · filed 2026-02-06 | $564.80M 10-Q · filed 2026-02-06 | $711.70M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $192.50M 10-Q · filed 2025-11-06 | $370.40M 10-Q · filed 2025-11-06 | $517.40M derived: sum of 3 quarters · filed 2026-08-07 | $690.80M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $178.00M 10-Q · filed 2026-08-07 | $324.90M derived: sum of 2 quarters · filed 2026-08-07 | $498.30M derived: sum of 3 quarters · filed 2026-08-07 | $649.70M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $146.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $320.30M derived: sum of 2 quarters · filed 2026-05-29 | $471.70M derived: sum of 3 quarters · filed 2026-05-29 | $611.60M 10-K · filed 2026-05-29 | $611.56M 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $173.40M 10-Q · filed 2026-02-06 | $173.36M 10-Q · filed 2025-02-07 | $324.80M derived: sum of 2 quarters · filed 2026-02-06 | $464.70M 10-Q · filed 2026-02-06 | $464.70M 10-Q · filed 2025-02-07 | $618.00M derived: sum of 4 quarters · filed 2026-02-06 | ||
| 2024-09-30 | $151.40M 10-Q · filed 2025-11-06 | $151.39M 10-Q · filed 2024-11-07 | $291.30M 10-Q · filed 2025-11-06 | $291.33M 10-Q · filed 2024-11-07 | $444.60M derived: sum of 3 quarters · filed 2025-11-06 | $593.20M derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | $139.90M 10-Q · filed 2025-08-07 | $139.95M 10-Q · filed 2024-08-08 | $293.20M derived: sum of 2 quarters · filed 2025-08-07 | $441.80M derived: sum of 3 quarters · filed 2025-08-07 | $562.60M derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $153.30M 10-K · filed 2024-05-29 | $301.90M derived: sum of 2 quarters · filed 2025-02-07 | $422.70M derived: sum of 3 quarters · filed 2025-02-07 | $553.30M 10-K · filed 2026-05-29 | $553.28M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $148.60M 10-Q · filed 2025-02-07 | $269.40M derived: sum of 2 quarters · filed 2025-02-07 | $399.98M 10-Q · filed 2025-02-07 | $582.18M derived: sum of 4 quarters · filed 2025-02-07 | ||||
| 2023-09-30 | $120.80M 10-Q · filed 2024-11-07 | $251.38M 10-Q · filed 2024-11-07 | $433.58M derived: sum of 3 quarters · filed 2024-11-07 | $564.58M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $130.58M 10-Q · filed 2024-08-08 | $312.78M derived: sum of 2 quarters · filed 2024-08-08 | $443.79M derived: sum of 3 quarters · filed 2024-08-08 | $567.69M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $182.20M 10-K · filed 2024-05-29 | $313.20M derived: sum of 2 quarters · filed 2024-05-29 | $437.11M derived: sum of 3 quarters · filed 2024-05-29 | $556.20M 10-K · filed 2025-05-29 | ||||
| 2022-12-31 | $131.00M 10-K · filed 2024-05-29 | $254.91M derived: sum of 2 quarters · filed 2024-05-29 | $374.00M derived: sum of 3 quarters · filed 2024-05-29 | |||||
| 2022-09-30 | $123.91M 10-K · filed 2024-05-29 | $242.99M derived: sum of 2 quarters · filed 2024-05-29 | ||||||
| 2022-06-30 | $119.08M 10-K · filed 2024-05-29 | |||||||
| 2022-03-31 | $284.46M 10-K · filed 2024-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |